NEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe ...
Morning Overview on MSN
Scientists finally crack mystery of rare blood clots after COVID shots
Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a rare clotting disorder that emerged in a small number of people who received ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...
A rare but serious clotting disorder linked to certain COVID-19 vaccines and natural adenovirus infections has puzzled ...
Traveling with Kristin on MSN
Could Americans travel to Europe during COVID?
During COVID in 2021, travel between the United States and Europe changed constantly. Entry rules depended on vaccination status, testing requirements, and which European country you were visiting. At ...
SARS-CoV-2 infections have been rising in the past month — global cases increased by more than 19,000 last month compared with the previous month, according to data posted on the World Health ...
A new consensus document from five subspecialty associations within the European Society of Cardiology gives recommendations for managing the cardiovascular consequences of COVID-19, spanning the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results